Truist has recently initiated Cyclerion Therapeutics Inc (CYCN) stock to Buy rating, as announced on October 20, 2021, according to Finviz. Earlier, on September 24, 2021, Cantor Fitzgerald had ...
On Wednesday, Outlook Therapeutics Inc (OTLK) stock saw a decline, ending the day at $1.7 which represents a decrease of $-3.19 or -65.24% from the prior close of $4.89. The stock opened at $0.98 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback